A new webinar focused on innovations and emerging tools in peptide science will take place on June 16, 2026, at 10:00 AM CET, offering researchers and lab professionals a closer look at technologies designed to strengthen and streamline peptide analysis, quality control, and manufacturing workflows. The session, sponsored by Agilent Technologies, will feature a lineup of experts addressing the practical challenges facing peptide-focused laboratories today.
The timing of the webinar reflects a broader moment in drug development, where peptide therapeutics have moved from a relatively niche modality to a central focus for many pharmaceutical and biotech pipelines. As that shift accelerates, the tools and workflows supporting peptide science are being asked to do more, faster, and with greater precision, making sessions like this one increasingly relevant to labs at every stage of the peptide development pipeline.
Addressing a growing area of drug development
Peptide therapeutics have become an increasingly important modality in modern drug development, sitting at the intersection of small-molecule chemistry and biologics. That dual nature brings with it a distinct set of analytical challenges: peptides must be characterized with the same rigor applied to small molecules while also accounting for the structural complexity, purity concerns, and manufacturing variability more commonly associated with larger biomolecules.
This hybrid identity is part of what makes peptide analysis so demanding. Small deviations in sequence, folding, or purity can meaningfully affect a peptide’s activity and safety profile, yet the analytical infrastructure historically built for small molecules or for biologics doesn’t always translate cleanly to a modality that straddles both categories. As peptide pipelines expand across the industry, laboratories are under growing pressure to ensure that purity, characterization, and quality control workflows can keep pace without becoming a bottleneck, particularly as programs move from early discovery into later-stage development and manufacturing.
Purity, characterization, and QC as connected challenges
Though often discussed separately, purity, characterization, and quality control in peptide science are closely interconnected. A purity issue identified late in a workflow can trace back to a characterization gap earlier in the process, while inconsistent QC practices can mask underlying purity problems that only surface during later development stages or regulatory review. Tools that treat these three areas as a connected system, rather than isolated checkpoints, tend to offer labs more reliable, reproducible results and fewer surprises as programs advance.
The webinar is positioned to address exactly this interconnected challenge, bringing together emerging tools aimed at making peptide workflows more accurate and more efficient across the full analytical pipeline, from initial characterization through ongoing quality control.
What attendees can expect
While the session will be presented by a range of experts rather than a single speaker, the focus remains consistent: equipping peptide scientists with practical tools that can be integrated into existing analysis, QC, and manufacturing processes. Rather than presenting purely theoretical advances, the format suggests an emphasis on applied solutions that labs can begin evaluating for their own workflows soon after the session concludes.
For laboratories working on peptide purification, structural characterization, or batch-to-batch consistency, the session offers an opportunity to hear directly from specialists working on solutions to these challenges. Given peptide science’s position at the crossover between small-molecule and biologic drug development, sessions of this kind often appeal to a broad audience, from analytical chemists focused on purity and structural confirmation to process scientists responsible for scaling manufacturing while maintaining consistent quality control standards.
Why this matters for peptide-focused labs
As more peptide candidates advance through pipelines industry-wide, the tools and standards used to evaluate them are under increasing scrutiny, both from internal quality teams and from regulators reviewing data packages. Labs that stay current with emerging analytical and QC technologies are often better positioned to move candidates through development efficiently, with fewer costly delays caused by purity or characterization issues discovered too late in the process.
Sessions like this webinar offer a relatively low-effort way for lab professionals to stay current with these developments, without requiring a significant time investment away from ongoing project work.
Registration details
The webinar is scheduled for June 16, 2026, at 10:00 AM CET, and is sponsored by Agilent Technologies. Those interested in strengthening their peptide analysis, QC, or manufacturing workflows can register to attend the live session and hear directly from the presenting experts.